buserelin has been researched along with Adenocarcinoma in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (74.29) | 18.7374 |
| 1990's | 7 (20.00) | 18.2507 |
| 2000's | 2 (5.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belanger, A; Chertin, B; Farkas, A; Fridmans, A; Hartman, H; Labrie, F; Spitz, IM | 1 |
| Bergman, R; Gez, E; Rozin, AP | 1 |
| Kirby, JD; Perry, L; Rustin, MH; Waxman, J | 1 |
| Allen, JM; Bloom, SR; Kerle, D; O'Shea, JP; Smith, C; Williams, G; Yeo, T | 1 |
| Bélanger, A; Dupont, A; Emond, J; Labrie, F; Monfette, G | 1 |
| Soloway, MS | 1 |
| Dufresne, M; Herrera, R; Koutsilieris, M; Martinez, A; Stellos, A; Tolis, G | 1 |
| Adenauer, H; Happ, J; Jacobi, GH; Krause, U; Wenderoth, UK | 1 |
| Belanger, A; Cusan, L; Dupont, A; Emond, JP; Fazekas, AT; Husson, JM; Laberge, JG; Labrie, F; Lacourciere, Y; Monfette, G; Raynaud, JP | 1 |
| Aro, J; Hansson, E; Juusela, H; Permi, J; Ruutu, M | 1 |
| Kataoka, A; Maruuchi, T; Nishida, T; Sugiyama, T; Yakushiji, M | 1 |
| Block, NL; Chodak, G; Gau, TC; Kennealey, G; Schellhammer, PF; Scott, M; Smith, JA; Soloway, MS; Vogelzang, NJ | 1 |
| Korczak, D; Lindner, A; Siegel, YI | 1 |
| Braf, Z; Greenstein, A; Matzkin, H | 1 |
| Andrén-Sandberg, A | 1 |
| Girsch, E; Kratzik, C; Kuber, W; Spona, J; Treu, T; Zeillinger, R | 1 |
| Heyman, J; Leiter, E | 1 |
| Hirasawa, K; Honma, Y; Isurugi, K; Kondo, Y; Oyamatsu, T | 1 |
| Hartmann, A; Mann, K | 1 |
| Irie, S; Matsumura, Y; Nagai, A; Nanba, K; Ohashi, T; Ohashi, Y; Ohmori, H; Tanahashi, T; Yamashita, Y | 1 |
| Cheson, BD | 1 |
| Argüelles, AE; Lascano, A; Poggi, U; Volmer, MC | 1 |
| Chin, JL; deHaan, HA; Greco, JM; Huben, RP; Murphy, GP; Scott, M | 1 |
| Aso, Y; Ishigami, J; Itatani, H; Kotake, T; Matsuda, M; Ohi, Y; Ohkawa, T; Okajima, E; Osafune, M; Usami, M | 1 |
| Ahmann, FR; Citrin, DL; deHaan, HA; Guinan, P; Jordan, VC; Kreis, W; Scott, M; Trump, DL | 1 |
| Ehrenthal, W; Hohenfellner, R; Jacobi, GH; Spindler, HW; von Wallenberg, H; Wenderoth, UK | 1 |
| Javadpour, N | 1 |
| Bélanger, A; Brun, D; Dupont, A; Gagné, C; Giguère, M; Labrie, F; Lupien, PJ; Moorjani, S | 1 |
| Inaba, T; Kojima, M; Miyashita, H; Ohe, H; Watanabe, H | 1 |
| Ackman, CF; Koutsilieris, M | 1 |
| Kennedy, PS; Klioze, SS; Mendez, RG; Naessig, VL; Presant, CA; Presant, SN; Soloway, MS; Todd, B; Wyres, MR; Yakabow, A | 1 |
| Falkson, G; Vorobiof, DA | 1 |
| Hubert, J; Lamy, P; Seigneur, J; Trechot, PF | 1 |
| Paulson, DF | 1 |
| Coombes, RC; Harland, SJ; Lister, TA; Malpas, JS; Powles, T; Waxman, JH; Wrigley, PF | 1 |
8 trial(s) available for buserelin and Adenocarcinoma
| Article | Year |
|---|---|
Advanced prostatic adenocarcinoma: biological aspects and effects of androgen deprivation achieved by castration or agonistic analogues of LHRH.
Topics: Acid Phosphatase; Adenocarcinoma; Alkaline Phosphatase; Bone and Bones; Buserelin; Hormones; Humans; Male; Neoplasm Staging; Orchiectomy; Prostate; Prostatic Neoplasms; Radiography; Receptors, Androgen; Ultrasonography | 1984 |
Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group.
Topics: Adenocarcinoma; Aged; Buserelin; Cardiovascular Diseases; Estradiol; Estradiol Congeners; Finland; Humans; Male; Prospective Studies; Prostatic Neoplasms | 1993 |
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group.
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Neoplasm Staging; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Testosterone | 1991 |
Zoladex (ICI 118,630): clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma.
Topics: Adenocarcinoma; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Male; Prostatic Neoplasms; Random Allocation; Time Factors | 1987 |
[Treatment of prostatic carcinoma with daily subcutaneous injection of the LH-RH analogue, ICI 118630].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Drug Evaluation; Gonadotropins, Pituitary; Goserelin; Humans; Injections, Subcutaneous; Male; Middle Aged; Prostatic Neoplasms; Random Allocation | 1986 |
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Drug Evaluation; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Statistics as Topic; Testosterone | 1987 |
Endocrine and clinical evaluation of 107 patients with advanced prostatic carcinoma under long-term pernasal buserelin or intramuscular decapeptyl depot treatment.
Topics: Adenocarcinoma; Administration, Intranasal; Antineoplastic Agents; Biomarkers, Tumor; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Lymphatic Metastasis; Male; Neoplasm Staging; Prostatic Neoplasms; Time Factors; Triptorelin Pamoate | 1988 |
Selected advances in therapy of urologic cancer--luteinizing hormone releasing hormone (LHRH) and biologic response modifier (BUR).
Topics: Adenocarcinoma; Buserelin; Clinical Trials as Topic; Delayed-Action Preparations; Goserelin; Humans; Injections, Subcutaneous; Interleukin-2; Male; Orchiectomy; Prostatic Neoplasms; Random Allocation; Recombinant Proteins | 1988 |
27 other study(ies) available for buserelin and Adenocarcinoma
| Article | Year |
|---|---|
Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Androgens; Anilides; Buserelin; Diarrhea; Flutamide; Gastrectomy; Glaucoma; Gonadotropin-Releasing Hormone; Hernia, Hiatal; Humans; Luteinizing Hormone; Male; Nitriles; Peptic Ulcer; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 2009 |
Recurrent auricular chondritis and cartilage repair.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Buserelin; Ear Cartilage; Ear Deformities, Acquired; Humans; Male; Polychondritis, Relapsing; Prostatic Neoplasms | 2005 |
Acne conglobata responding to buserelin, a gonadotrophin-releasing hormone analogue.
Topics: Acne Vulgaris; Adenocarcinoma; Aged; Buserelin; Humans; Male; Prostatic Neoplasms | 1983 |
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Topics: Adenocarcinoma; Buserelin; Castration; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1984 |
Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer.
Topics: Acid Phosphatase; Adenocarcinoma; Androgen Antagonists; Buserelin; Drug Therapy, Combination; Humans; Imidazoles; Imidazolidines; Male; Prostatic Neoplasms; Testosterone | 1984 |
Newer methods of hormonal therapy for prostate cancer.
Topics: Adenocarcinoma; Aminoglutethimide; Androgen Antagonists; Bone Neoplasms; Buserelin; Flutamide; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms | 1984 |
Endocrine studies with a gonadotropin-releasing hormone analogue to achieve withdrawal of testosterone in prostate carcinoma patients.
Topics: Adenocarcinoma; Administration, Intranasal; Aged; Buserelin; Gonadotropin-Releasing Hormone; Hormones; Humans; Luteinizing Hormone; Male; Middle Aged; Monitoring, Physiologic; Prolactin; Prostatic Neoplasms; Testosterone | 1982 |
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.
Topics: Adenocarcinoma; Androgen Antagonists; Animals; Bone Neoplasms; Buserelin; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Imidazolidines; Male; Prostatic Neoplasms; Rats | 1982 |
Effects of a gonadotropin-releasing hormone agonist on rat ovarian adenocarcinoma cell lines in vitro and in vivo.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Buserelin; Cell Division; Chorionic Gonadotropin; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Ovarian Neoplasms; Progesterone; Rats; Rats, Wistar; Tumor Cells, Cultured | 1998 |
Serum prolactin levels in patients treated with a gonadotropin-releasing hormone analogue for adenocarcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Buserelin; Follow-Up Studies; Humans; Male; Prolactin; Prostatic Neoplasms; Time Factors | 1991 |
Clinical importance of prostatic measurements in follow-up of GnRH analogue-treated prostatic carcinoma patients.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers, Tumor; Buserelin; Follow-Up Studies; Humans; Male; Middle Aged; Prostate; Prostatic Neoplasms; Remission Induction; Survival Rate; Ultrasonography; Urination | 1990 |
Treatment with an LHRH analogue in patients with advanced pancreatic cancer. A preliminary report.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Buserelin; Drug Implants; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies | 1990 |
[Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Animals; Buserelin; Carcinoma; Drug Implants; Goserelin; Humans; Male; Middle Aged; Organ Size; Prospective Studies; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Testis; Testosterone | 1990 |
Dramatic response of pulmonary metastasis from prostatic cancer to LH-RH agonist treatment.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Gonadotropin-Releasing Hormone; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Rectal Diseases; Ulcer | 1989 |
[Testicular endocrine function in patients with prostatic cancer receiving medical castration by long-term administration of LH-RH agonists].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Buserelin; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Testis; Testosterone | 1989 |
[Therapy with LHRH analogs in a 41-year-old patient with metastatic breast cancer].
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Femoral Neoplasms; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Male; Tamoxifen; Triptorelin Pamoate | 1989 |
[Clinical and endocrinological studies of the luteinizing hormone-releasing hormone analogue therapy in prostatic cancer patients].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgens; Antineoplastic Agents; Buserelin; Dihydrotestosterone; Drug Evaluation; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Remission Induction; Testosterone | 1989 |
Clinical trials referral resource. Adjuvant therapy of breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Goserelin; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Menopause; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen | 1989 |
Lung metastases of prostate carcinoma cleared by intranasal GRH analogue.
Topics: Adenocarcinoma; Administration, Intranasal; Aged; Buserelin; Humans; Lung Neoplasms; Male; Prostatic Neoplasms | 1985 |
Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Humans; Imidazoles; Imidazolidines; Lipoproteins, HDL; Male; Prostatic Neoplasms | 1987 |
Kinetic evaluation of the effect of LHRH analog on prostatic cancer using transrectal ultrasonotomography.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Kinetics; Luteinizing Hormone; Male; Prostate; Prostatic Neoplasms; Testosterone; Ultrasonography | 1987 |
Complete response of lung metastases caused by prostatic cancer after chronic administration of a gonadotropin-releasing hormone analog, buserelin (HOE 766).
Topics: Adenocarcinoma; Aged; Buserelin; Humans; Lung; Lung Neoplasms; Male; Prostatic Neoplasms; Radiography | 1987 |
Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of life.
Topics: Adenocarcinoma; Aged; Buserelin; Follow-Up Studies; Humans; Male; Prostatic Neoplasms; Quality of Life | 1987 |
Intranasal buserelin in the treatment of advanced prostatic cancer: a phase II trial.
Topics: Adenocarcinoma; Administration, Intranasal; Aged; Aged, 80 and over; Antineoplastic Agents; Buserelin; Drug Evaluation; Humans; Male; Middle Aged; Prostatic Neoplasms | 1987 |
Pulmonary complications of hormone treatment in prostate carcinoma.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Buserelin; Drug Therapy, Combination; Humans; Imidazoles; Imidazolidines; Male; Prostatic Neoplasms; Pulmonary Fibrosis | 1988 |
Management of metastatic prostatic cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Castration; Cyclophosphamide; Diethylstilbestrol; Estramustine; Gonadotropin-Releasing Hormone; Hormones; Humans; Leuprolide; Male; Neoplasm Metastasis; Prostatic Neoplasms | 1985 |
The treatment of postmenopausal women with advanced breast cancer with buserelin.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Buserelin; Female; Gonadotropins, Pituitary; Humans; Hypophysectomy, Chemical; Lymphatic Metastasis; Menopause; Middle Aged; Time Factors | 1985 |